Understanding the barriers and facilitators related to never treatment during mass drug administration among mobile and migrant populations in Mali: a qualitative exploratory study

This study highlights that there are people with high mobility who may never have been treated during any round of MDA. The reasons for never treatment highlight the challenges faced when reaching particular groups during MDA activities/interventions. Suggested remedies will require programmes to implement more flexible and tailored interventions. Customised approaches based on the context are essential to guarantee fair access to preventive chemotherapy. Effective interventions must consider the supply and demand side in crafting interventions. This research adds to the evidence base to understand never treatment, particularly among highly mobile population groups and in schistosomiasis elimination programmes.

Authors

Institutions

Publication Details

Journal
BMJ Global Health
Published
2024-10-01
DOI
https://doi.org/10.1136/bmjgh-2024-015671
Citations
6
Primary Topic
Global Maternal and Child Health
Type
article
Field-Weighted Citation Impact
6.66

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Understanding the barriers and facilitators related to never treatment during mass drug administration among mobile and migrant populations in Mali: a qualitative exploratory study

Moussa Sangare, Alison Krentel, Abdoul Fatao Diabaté, Housséini Dolo et al.
6 citations
BMJ Global Health
Global Maternal and Child Health
6.66
article

Understanding the barriers and facilitators related to never treatment during mass drug administration among mobile and migrant populations in Mali: a qualitative exploratory study

Moussa Sangare, Alison Krentel, Abdoul Fatao Diabaté, Housséini Dolo, Thomas B. Nutman, Sekou Oumarou Thera, Manisha A. Kulkarni, Ilo Dicko, Yaya Ibrahim Coulibaly, Diadje Tanapo, Binta Sall, Oumar Coulibaly, Fatoumata Traoré, Seydou Doumbia
article en
6 citations

Abstract

This study highlights that there are people with high mobility who may never have been treated during any round of MDA. The reasons for never treatment highlight the challenges faced when reaching particular groups during MDA activities/interventions. Suggested remedies will require programmes to implement more flexible and tailored interventions. Customised approaches based on the context are essential to guarantee fair access to preventive chemotherapy. Effective interventions must consider the supply and demand side in crafting interventions. This research adds to the evidence base to understand never treatment, particularly among highly mobile population groups and in schistosomiasis elimination programmes.

BMJ Global HealthVol. 9(10)
University of Ottawa (CA), University of Bamako (ML), Université des Sciences, des Techniques et des Technologies de Bamako (ML), National Institute of Allergy and Infectious Diseases (US), Bruyère (CA)
Bill and Melinda Gates Foundation, Government of the United Kingdom
Good health and well-being
Openalex Percentile: Top 4%
Global Maternal and Child Health
6.66
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.